Sumatriptan Succinate Tablet
Product Images NDC 68071-2283

4 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 68071-2283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2283 9)

Pdp (68071 2283 9)
Label for Sumatriptan 100 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates this is a prescription drug with #9 Unit of Use Tablets per package. The label includes the NDC 68071-2283-9 and references manufacturing by Dr. Reddy's Laboratories Limited in India. Directions for use and warnings are present, with storage at controlled temperature 68-77°F advised.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph showing the estimated probability of response over time (up to 240 minutes) after initial dose for Sumatriptan Saccharinate tablets at doses of 25 mg, 50 mg, and 100 mg, compared to placebo. The y-axis represents probability percentages, and the x-axis represents time in minutes.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing the estimated probability of remediation or rescue over 24 hours from the initial dose. The graph compares placebo with Sumatriptan Succinate tablets at doses of 25 mg, 50 mg, and 100 mg. The x-axis represents time in hours from initial dose, and the y-axis shows probability percentages from 0% to 100%. The placebo line peaks near 80%, while the Sumatriptan doses have lower peak probabilities, increasing with dose.*
FDA Label Image

Strucure (Structure)

Strucure (Structure)
Chemical structure of Sumatriptan Succinate. The diagram shows the molecular arrangement including an indole ring, sulfonamide group, and the succinate moiety represented with carboxyl groups and ethylene linkages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.